These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 12724582

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clopidogrel and aspirin versus aspirin alone in prevention of atherothrombotic events. The results of CHARISMA study].
    Gaciong Z.
    Kardiol Pol; 2006 May; 64(5):548-51; discussion 551-2. PubMed ID: 16752345
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
    Lindgren P, Stenestrand U, Malmberg K, Jönsson B.
    Clin Ther; 2005 Jan; 27(1):100-10. PubMed ID: 15763611
    [Abstract] [Full Text] [Related]

  • 9. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
    Steinhubl S, Roe MT.
    Cardiovasc Drug Rev; 2007 Jan; 25(2):188-203. PubMed ID: 17614940
    [Abstract] [Full Text] [Related]

  • 10. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S, Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial.
    Circulation; 2004 Sep 07; 110(10):1202-8. PubMed ID: 15313956
    [Abstract] [Full Text] [Related]

  • 11. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
    Peters RJ, Mehta SR, Fox KA, Zhao F, Lewis BS, Kopecky SL, Diaz R, Commerford PJ, Valentin V, Yusuf S, Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators.
    Circulation; 2003 Oct 07; 108(14):1682-7. PubMed ID: 14504182
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.
    Storey RF, Husted S, Harrington RA, Heptinstall S, Wilcox RG, Peters G, Wickens M, Emanuelsson H, Gurbel P, Grande P, Cannon CP.
    J Am Coll Cardiol; 2007 Nov 06; 50(19):1852-6. PubMed ID: 17980251
    [Abstract] [Full Text] [Related]

  • 15. Does combined clopidogrel and statin therapy benefit patients with non-ST-elevation myocardial infarction?
    Altman R.
    Nat Clin Pract Cardiovasc Med; 2005 Nov 06; 2(11):558-9. PubMed ID: 16258563
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
    Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, Winters KJ, Warmke JW, McCabe CH, Braunwald E, TRITON-TIMI 38 Investigators.
    Am Heart J; 2006 Oct 06; 152(4):627-35. PubMed ID: 16996826
    [Abstract] [Full Text] [Related]

  • 17. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
    Lewis BS, Mehta SR, Fox KA, Halon DA, Zhao F, Peters RJ, Keltai M, Budaj A, Yusuf S, CURE trial investigators.
    Am Heart J; 2005 Dec 06; 150(6):1177-84. PubMed ID: 16338255
    [Abstract] [Full Text] [Related]

  • 18. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.
    Chen WH, Lee PY, Ng W, Tse HF, Lau CP.
    J Am Coll Cardiol; 2004 Mar 17; 43(6):1122-6. PubMed ID: 15028378
    [Abstract] [Full Text] [Related]

  • 19. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z, Kala P.
    Clin Ther; 2008 Mar 17; 30 Pt 2():2191-202. PubMed ID: 19281914
    [Abstract] [Full Text] [Related]

  • 20. Dual antiplatelet drug resistance in patients with acute coronary syndrome.
    Guha S, Sardar P, Guha P, Roy S, Mookerjee S, Chakrabarti P, Deb PK, Chaudhuri U, Deb S, Karmakar R, Dasgupta AK, Lahiri P.
    Indian Heart J; 2009 Mar 17; 61(1):68-73. PubMed ID: 19729693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.